Literature DB >> 11489051

Cancer incidence among people with intellectual disability.

K Patja1, P Eero, M Iivanainen.   

Abstract

The aim of the present study was to address the unresolved question of the risk of neoplasms among people with intellectual disability (ID). A total of 2173 individuals with ID from a large, representative, nation-wide population study conducted in Finland in 1962 were followed-up for cancer incidence between 1967 and 1997. Standardized incidence ratios (SIRs) were defined as ratios of observed to expected numbers of cancer cases. Expected rates were based on national incidence rates. The observed number of cancers in the cohort (173) was close to what was expected [SIR = 0.9, 95% confidence interval (95% CI) = 0.8-1.0]. There was a significantly reduced risk of cancers of the prostate (SIR = 0.2, 95% CI = 0.0-0.5), urinary tract (SIR = 0.3, 95% CI = 0.1-0.7) and lung (SIR = 0.6, 95% CI = 0.4-1.0). The risk was increased in cancers of the gallbladder (SIR = 2.8, 95% CI = 1.1-5.8) and thyroid gland (SIR = 2.1, 95% CI = 1.0-4.8). The risks of lung and gallbladder cancer were lowest and highest, respectively, in those subjects with profound and severe ID, a group who also had significantly elevated SIRs for brain cancer (SIR = 3.46, 95% CI = 1.5-14.4) and testicular cancer (SIR = 9.9, 95% CI = 1.2-35.6). The incidence of cancer among people with ID was comparable with the general population, despite their low prevalence of smoking and apparently decreased diagnostic screening activity. Nevertheless, a few types of cancer carry a higher risk in the population with ID, possibly because of conditions typical among this group, such as gallstones or oesophageal reflux.

Entities:  

Mesh:

Year:  2001        PMID: 11489051     DOI: 10.1046/j.1365-2788.2001.00322.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  30 in total

1.  Breast screening guidelines should be adapted in Down's syndrome.

Authors:  Daniel Satgé; Annie J Sasco
Journal:  BMJ       Date:  2002-05-11

2.  Health conditions associated with aging and end of life of adults with Down syndrome.

Authors:  Anna J Esbensen
Journal:  Int Rev Res Ment Retard       Date:  2010

Review 3.  Screening tests for adults with intellectual disabilities.

Authors:  Joanne E Wilkinson; Larry Culpepper; Mary Cerreto
Journal:  J Am Board Fam Med       Date:  2007 Jul-Aug       Impact factor: 2.657

4.  Determinants of cervical cancer screening among women with intellectual disabilities: evidence from medical records.

Authors:  Susan L Parish; Jamie G Swaine; Esther Son; Karen Luken
Journal:  Public Health Rep       Date:  2013 Nov-Dec       Impact factor: 2.792

Review 5.  Health disparities between women with and without disabilities: a review of the research.

Authors:  Jennifer P Wisdom; Marjorie G McGee; Willi Horner-Johnson; Yvonne L Michael; Elizabeth Adams; Michelle Berlin
Journal:  Soc Work Public Health       Date:  2010-05

6.  Determinants of mammography in women with intellectual disabilities.

Authors:  Joanne E Wilkinson; Emily Lauer; Karen M Freund; Amy K Rosen
Journal:  J Am Board Fam Med       Date:  2011 Nov-Dec       Impact factor: 2.657

Review 7.  Aspects of digestive tract tumors in Down syndrome: a literature review.

Authors:  Daniel Satgé; Annie J Sasco; Michel J J Vekemans; Marie-Laure Portal; Jean-François Fléjou
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

8.  Testing the feasibility of a DVD-based intervention to promote preparedness for mammography in women with intellectual disabilities.

Authors:  Nechama W Greenwood; Claire Tienwey Wang; Deborah Bowen; Joanne Wilkinson
Journal:  J Cancer Educ       Date:  2014-03       Impact factor: 2.037

Review 9.  Primary care for women with intellectual disabilities.

Authors:  Joanne E Wilkinson; Mary C Cerreto
Journal:  J Am Board Fam Med       Date:  2008 May-Jun       Impact factor: 2.657

10.  Cancer treatment in disabled children.

Authors:  Cristina Meazza; Elisabetta Schiavello; Veronica Biassoni; Marta Podda; Chiara Barteselli; Francesco Barretta; Giovanna Gattuso; Monica Terenziani; Andrea Ferrari; Filippo Spreafico; Roberto Luksch; Michela Casanova; Stefano Chiaravalli; Nadia Puma; Luca Bergamaschi; Maura Massimino
Journal:  Eur J Pediatr       Date:  2020-03-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.